SCHEMBL20660751

SCHEMBL20660751

Cc1cc(Br)ccc1N(C)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
C5AR1 P21730 1/20 0.38
MEN1 O00255 4/20 0.38
KMT2A Q03164 4/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
MAPT P10636 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NCEH1 Q6PIU2 1/20 0.37
MYC P01106 1/20 0.37
NR4A1 P22736 1/20 0.37
LMNA P02545 3/20 0.36
POLB P06746 1/20 0.36
KDM4E B2RXH2 2/20 0.36
HRH4 Q9H3N8 1/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18894248 0.85 ALDH1A1 (0.41) ALDH1A1C5AR1CYP1A2CYP2C9CYP2C19
SCHEMBL935058 0.81 MEN1 (0.40) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL21396202 0.80 HRH4 (0.39) ALDH1A1C5AR1MEN1KMT2ACYP1A2
SCHEMBL17420936 0.80 SIRT2 (0.48) ALDH1A1KMT2AMAPTNCEH1LMNA
SCHEMBL28356743 0.80 ALDH1A1 (0.36) ALDH1A1C5AR1MEN1KMT2ACYP1A2
SCHEMBL1000327 0.78 LMNA (0.40) ALDH1A1MEN1KMT2AMAPTNCEH1
SCHEMBL1018391 0.78 PDE10A (0.44) ALDH1A1MEN1KMT2ACYP1A2MAPT
SCHEMBL728476 0.77 KMT2A (0.35) ALDH1A1C5AR1MEN1KMT2ACYP1A2
SCHEMBL2191688 0.77 RAB9A (0.37) ALDH1A1C5AR1MEN1KMT2ACYP1A2
SCHEMBL20671184 0.77 AAK1 (0.40) ALDH1A1NCEH1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS AHR, ARNT, RXRB ALDH1A1 879/4885C5AR1 1060/4885MEN1 4372/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB ALDH1A1 879/4885C5AR1 1060/4885MEN1 4372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.